Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pain in multiple sclerosis].

M Chatel1, M Lantéri-Minet, C Lebrun-Frenay

  • 1Service de Neurologie, Hôpital Pasteur, CHRU Nice.

Revue Neurologique
|January 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in the real-world management of cluster headache patients treated by subcutaneous sumatriptan and/or oxygen in France - An analysis of the French National Social Security System Open Data over eleven years (2014-2024).

Revue neurologique·2025
Same author

Cluster headache suicidality: a systematic review with a meta-analysis.

The journal of headache and pain·2025
Same author

Discussing with our patient a presymptomatic adult-onset neurological disease.

Revue neurologique·2025
Same author

Presymptomatic multiple sclerosis: Insights from the Radiologically Isolated Syndrome.

Revue neurologique·2025
Same author

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study.

The journal of headache and pain·2025
Same author

Cluster headache diagnostic delay and its predictors: a systematic review with a meta-analysis.

The journal of headache and pain·2025
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Pain significantly impacts Multiple Sclerosis (MS) patients, affecting over half of them. Effective management requires precise diagnosis of neuropathic or nociceptive pain for tailored treatment strategies.

Area of Science:

  • Neurology
  • Pain Medicine
  • Neuroimmunology

Context:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • Pain is a prevalent and debilitating symptom in over 50% of MS patients.
  • Current clinical focus often prioritizes disease-modifying treatments over symptomatic pain management.

Purpose:

  • To highlight the significant impact of pain on the quality of life for Multiple Sclerosis patients.
  • To emphasize the need for accurate diagnosis differentiating neuropathic and nociceptive pain mechanisms.
  • To advocate for tailored treatment strategies based on pain type in MS care.

Summary:

  • Pain is a pervasive issue in Multiple Sclerosis, affecting quality of life and often undertreated.
  • Diagnosis must distinguish between central neuropathic and nociceptive pain to guide therapy.

Related Experiment Videos

  • Treatment approaches vary, including antispasmodics, antiepileptics, anti-inflammatories, and opioids, depending on the pain mechanism.

    • Impact:

    • Improved patient outcomes through targeted pain management in Multiple Sclerosis.
    • Enhanced clinical practice by integrating comprehensive pain assessment into MS care protocols.
    • Reduced burden on patients by addressing a key factor affecting their quality of life.